Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 3, 2025 -- For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, metabolic surgery is associated with a lower risk for incident major adverse liver outcomes (MALO), according to a study published online Jan. 27 in Nature Medicine.
Ali Aminian, M.D., from the Bariatric and Metabolic Institute at the Cleveland Clinic, and colleagues conducted an observational study to compare the effects of metabolic surgery and nonsurgical treatment in patients with obesity and compensated histologically proven MASH-related cirrhosis. The time-to-incident MALO was compared for 62 patients who underwent metabolic surgery and 106 nonsurgical controls who were followed for a mean of 10.0 ± 4.5 years.
The researchers found that the 15-year cumulative incidence of MALO was 20.9 and 46.4 percent in the surgical and nonsurgical groups, respectively, with an adjusted hazard ratio of 0.28. The 15-year cumulative incidence of decompensated cirrhosis was 15.6 and 30.7 percent in the surgical and nonsurgical groups, respectively (adjusted hazard ratio, 0.20).
"In the absence of approved medical therapies for compensated MASH-related cirrhosis, metabolic surgery may represent a safe and effective therapeutic option to influence the trajectory of cirrhosis in selected patients," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Prescriptions for Obesity Management Drugs Increasing
THURSDAY, Feb. 6, 2025 -- Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends, according to a...
Ultraprocessed Food Consumption in Early Childhood Tied to Obesity
WEDNESDAY, Feb. 5, 2025 -- High ultraprocessed food (UPF) consumption during early childhood is associated with obesity development, primarily in males, according to a study...
Dose-Dependent Link Seen for Alcohol, Cirrhosis, Liver Cancer in Patients With Hep B
WEDNESDAY, Jan. 29, 2025 -- For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.